Virtual Library

Start Your Search

S. Peters



Author of

  • +

    P1.25 - Poster Session 1 - Nurses (ID 248)

    • Event: WCLC 2013
    • Type: Poster Session
    • Track: Nurses
    • Presentations: 1
    • +

      P1.25-002 - Testing the feasibility of a lung cancer nurse coordination model during early treatment: phase II study (Clinical Trial in Progress) (ID 1124)

      09:30 - 09:30  |  Author(s): S. Peters

      • Abstract

      Background
      To develop adequate self-care strategies, patients with lung cancer and their families are in need of emotional, informational and behavioural supportive care. Supportive care in cancer can reduce symptom burden and improve patients and their families self-management skills. As lung cancer incidence continues to rise, and increased attention is given to early diagnosis, research on early involvement of lung cancer nurse (LCN) in care, the feasibility and impact on patient outcomes is needed. The primary aim of this study is to assess the feasibility and acceptability of a LCN model of care commenced during first line of chemotherapy, and the impact on patient self-reported changes in self-efficacy, symptoms and supportive care needs. In addition perceived barriers and facilitators for the application of the LCN model will be examined.

      Methods
      An exact single-stage phase II design will be conducted. Lung cancer patients with planned chemotherapy with or without radiotherapy will be recruited at the thoracic cancer center in a Swiss University Hospital. The LCN model of care consists of two face-to-face consultations alternating with two telephone consultations during first line of chemotherapy. LCN consultations will comprise focused assessment of physical and psychological symptoms, information (printed and oral) about disease and its treatment, therapeutic education concerning strategies to manage physical and psychosocial symptoms and review of available support resources. Participants will be invited to complete the validated patient reported Lung Cancer Symptom Scale, Supportive Care Needs Screening Tool 9 and Self-Efficacy Scale for Lung Cancer. Study data will be collected at baseline (day 1 of 1[st] chemotherapy cycle), time 1 (week 3 of 2[nd] cycle) and time 2 (week 3 of 3[rd] cycle). Participants will be categorized as compliant if they complete all their scheduled LCN consultations and questionnaires. For a 5% probability of accepting a poor feasibility (alpha) and a 20% probability of rejecting an acceptable feasibility (beta) we then need to enroll 71 patients. Feasibility will be considered as acceptable for further studies if at least 36 patients will be compliant. Secondary outcomes will be analyzed descriptively for each variable (self-efficacy, symptoms and supportive care needs) across each time point. At the end of quantitative data collection, a focus group will be conducted to explore acceptability of the new role among health professionals working with the LCN in order to identify perceived barriers and facilitators for collaborative work with the new role.

      Results
      N.A.

      Conclusion
      This project is expected to have direct impact on enhancing the quality of supportive care for patients with lung cancer. Findings will provide evidence for refining the LCN model prior to embarking on a full-scale evaluation using a comparative experimental design. Furthermore, phase II designs have rarely been applied to psycho-social interventions. This method could give new insights to the nursing and allied health professionals how to investigate the efficacy and feasibility as well as the needed intensity of newly developed interventions in order to improving supportive care in oncology.